From startups to major research organizations, early-phase research can be managed in different ways depending on the company.
Colleen Hoke, Co-Founder and CEO of ObjectiveHealth discusses her career in early-phase research and the transition from working with a startup to a major research organization. She also touches on what her current company, ObjectiveHealth is working on, leadership skills, and the evolution of clinical research.
Having held leadership and executive positions at clinical research organizations, specialty providers, and healthcare entities, Colleen has more than 25 years of experience in the areas of business development, organizational management, and executive team building. She was a key member of an executive team that built a successful early-phase research site that was later acquired by a major research corporation, and she has contributed to best practice standards for the Association of Clinical Pharmacology Units (ACPU). Colleen holds a bachelor’s degree of science from the University of Tennessee and is a graduate of the Wharton School of Business Executive Leadership course.
The editors of Applied Clinical Trials bring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.
